{
    "code": "01014664",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01014664",
    "time": "2020-02-25 02:27:58",
    "許可證字號": "衛署藥製字第014664號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/01\/17",
    "註銷理由": "自請註銷",
    "有效日期": "102\/04\/17",
    "發證日期": "67\/04\/17",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101466400",
    "中文品名": "的剎美剎松注射液",
    "英文品名": "DEXAMETHASONE INJECTION &quot;WINSTON&quot;",
    "適應症": "急性副腎皮質機能不全、腦下垂體前葉機能失調、侵襲性休克重症感染、氣喘、急性藥物中毒、關節炎、滑液囊炎、腱炎、筋炎、汎發性結合組織炎、皮膚炎、苔癬、蕁麻疹",
    "劑型": "270注射劑",
    "包裝": "安瓿 小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "1217820200  溫士頓醫藥股份有限公司",
        "申請商地址": "台南市永康區鹽洲里仁愛街１１７號",
        "主製造廠": ""
    },
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804008640",
            "成分名稱": "DEXAMETHASONE PHOSPHATE (SODIUM)",
            "含量描述": "(4.373MG) 4",
            "含量": "",
            "單位": "MG"
        }
    ]
}